Equivalent functions for B7.1 and B7.2 costimulation in mediating host resistance to Mycobacterium tuberculosis

Cellular Immunology

Volumn 285, Issue 1-2, 2013, Pages 69-75

  Bhatt, Kamlesh ^a   Kim, Andrew ^a   Kim, Angela ^b   Mathur, Sanjeev ^c   Salgame, Padmini ^a  

^a RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

^b ST CHRISTOPHER'S HOSPITAL FOR CHILDREN   (United States)

^c UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

Author keywords

B7.1; B7.2; Costimulation; Granuloma; Mouse; Mycobacterium tuberculosis; Th1

Indexed keywords

B7.1 ANTIGEN; CD28 ANTIGEN; CD86 ANTIGEN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; LYMPHOCYTE ANTIGEN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL LOAD; CONTROLLED STUDY; FEMALE; HOST RESISTANCE; IMMUNOCOMPETENT CELL; LUNG; LUNG GRANULOMATOSIS; LUNG PARENCHYMA; LYMPHOCYTE ACTIVATION; MOUSE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; TH1 CELL; TUBERCULOSIS; WILD TYPE;

B7.1; B7.2; COSTIMULATION; GRANULOMA; MOUSE; MYCOBACTERIUM TUBERCULOSIS; TH1;

ANIMALS; ANTIGEN-PRESENTING CELLS; ANTIGENS, CD28; ANTIGENS, CD80; ANTIGENS, CD86; CELLS, CULTURED; CTLA-4 ANTIGEN; CYTOKINES; FEMALE; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, KNOCKOUT; MYCOBACTERIUM TUBERCULOSIS; TUBERCULOSIS;

EID: 84884925586     PISSN: 00088749     EISSN: 10902163     Source Type: Journal    
DOI: 10.1016/j.cellimm.2013.09.004     Document Type: Article

References (37)

1. Sharpe A.H. Mechanisms of costimulation. Immunol. Rev. 2009, 229(1):5-11.
2. Sharpe A.H., Freeman G.J. The B7-CD28 superfamily. Nat. Rev. Immunol. 2002, 2(2):116-126.
3. Munn D.H., Sharma M.D., Mellor A.L. Ligation of B7-1/B7-2 by human CD4+ T cells triggers indoleamine 2,3-dioxygenase activity in dendritic cells. J. Immunol. 2004, 172(7):4100-4110.
4. Lohr J., et al. The inhibitory function of B7 costimulators in T cell responses to foreign and self-antigens. Nat. Immunol. 2003, 4(7):664-669.
5. Butte M.J., et al. Programmed death-1 ligand 1 interacts specifically with the B7-1 costimulatory molecule to inhibit T cell responses. Immunity 2007, 27(1):111-122.
6. Salomon B., Bluestone J.A. Complexities of CD28/B7: CTLA-4 costimulatory pathways in autoimmunity and transplantation. Annu. Rev. Immunol. 2001, 19:225-252.
7. Kuchroo V.K., et al. B7-1 and B7-2 costimulatory molecules activate differentially the Th1/Th2 dvelopmental pathways: Application to autoimmune disease therapy. Cell 1995, 80:707-718.
8. Racke M.K., et al. Distinct roles for B7-1 (CD-80) and B7-2 (CD-86) in the initiation of experimental allergic encephalomyelitis. J. Clin. Investig. 1995, 96(5):2195-2203.
9. Puliti M., Bistoni F., Tissi L. Lack of B7-1 and B7-2 costimulatory molecules modulates the severity of group B Streptococcus-induced arthritis. Microbes Infect. 2010, 12(4):302-308.
10. Yadav D., et al. B7-1 mediated costimulation regulates pancreatic autoimmunity. Mol. Immunol. 2007, 44(10):2616-2624.
11. Kinoshita K., et al. Costimulation by B7-1 and B7-2 is required for autoimmune disease in MRL-Faslpr mice. J. Immunol. 2000, 164(11):6046-6056.
12. Webb L.M., Walmsley M.J., Feldmann M. Prevention and amelioration of collagen-induced arthritis by blockade of the CD28 co-stimulatory pathway: requirement for both B7-1 and B7-2. Eur. J. Immunol. 1996, 26(10):2320-2328.
13. Odobasic D., et al. Distinct in vivo roles of CD80 and CD86 in the effector T-cell responses inducing antigen-induced arthritis. Immunology 2008, 124(4):503-513.
14. Silver P.B., et al. Blockade of costimulation through B7/CD28 inhibits experimental autoimmune uveoretinitis, but does not induce long-term tolerance. J. Immunol. 2000, 165(9):5041-5047.
15. Bagenstose L.M., et al. B7-1 and B7-2 co-stimulatory molecules are required for mercury-induced autoimmunity. Clin. Exp. Immunol. 2002, 127(1):12-19.
16. Brown J.A., et al. Blockade of CD86 ameliorates Leishmania major infection by down-regulating the Th2 response. J. Infect. Dis. 1996, 174(6):1303-1308.
17. Brown J.A., et al. T helper differentiation in resistant and susceptible B7-deficient mice infected with Leishmania major. Eur. J. Immunol. 2002, 32(6):1764-1772.
18. Salek-Ardakani S., et al. Preferential use of B7.2 and not B7.1 in priming of vaccinia virus-specific CD8 T cells. J. Immunol. 2009, 182(5):2909-2918.
19. McAdam A.J., et al. B7 costimulation is critical for antibody class switching and CD8(+) cytotoxic T-lymphocyte generation in the host response to vesicular stomatitis virus. J. Virol. 2000, 74(1):203-208.
20. Lyon A.B., Sarawar S.R. Differential requirement for CD28 and CD80/86 pathways of costimulation in the long-term control of murine gammaherpesvirus-68. Virology 2006, 356(1-2):50-56.
21. Lu P., et al. CTLA-4 ligands are required to induce an in vivo interleukin 4 response to a gastrointestinal nematode parasite. J. Exp. Med. 1994, 180(2):693-698.
22. Urban J., et al. IL-13-mediated worm expulsion is B7 independent and IFN-gamma sensitive. J. Immunol. 2000, 164(8):4250-4256.
23. Subramanian G., et al. B7-2 requirement for helminth-induced granuloma formation and CD4 type 2 T helper cell cytokine expression. J. Immunol. 1997, 158(12):5914-5920.
24. Greenwald R.J., et al. Effects of blocking B7-1 and B7-2 interactions during a type 2 in vivo immune response. J. Immunol. 1997, 158(9):4088-4096.
25. Liu Z., et al. Nippostrongylus brasiliensis can induce B7-independent antigen-specific development of IL-4-producing T cells from naive CD4 T cells in vivo. J. Immunol. 2002, 169(12):6959-6968.
26. Bhatt K., et al. B7 costimulation is critical for host control of chronic Mycobacterium tuberculosis infection. J. Immunol. 2009, 182(6):3793-3800.
27. Lazarevic V., et al. Induction of Mycobacterium tuberculosis-specific primary and secondary T-cell responses in interleukin-15-deficient mice. Infect. Immun. 2005, 73(5):2910-2922.
28. Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 2001, 25(4):402-408.
29. Johnson C.M., et al. Adequate expression of protective immunity in the absence of granuloma formation in Mycobacterium tuberculosis-infected mice with a disruption in the intracellular adhesion molecule 1 gene. Infect. Immun. 1998, 66(4):1666-1670.
30. Saunders B.M., et al. CD4 is required for the development of a protective granulomatous response to pulmonary tuberculosis. Cell. Immunol. 2002, 216(1-2):65-72.
31. Wang S., Chen L. T lymphocyte co-signaling pathways of the B7-CD28 family. Cell. Mol. Immunol. 2004, 1(1):37-42.
32. Collins A.V., et al. The interaction properties of costimulatory molecules revisited. Immunity 2002, 17(2):201-210.
33. Greene J.L., et al. Covalent dimerization of CD28/CTLA-4 and oligomerization of CD80/CD86 regulate T cell costimulatory interactions. J. Biol. Chem. 1996, 271(43):26762-26771.
34. Inaba K., et al. The tissue distribution of the B7-2 costimulator in mice: abundant expression on dendritic cells in situ and during maturation in vitro. J. Exp. Med. 1994, 180(5):1849-1860.
35. Maglione P.J., Xu J., Chan J. B cells moderate inflammatory progression and enhance bacterial containment upon pulmonary challenge with Mycobacterium tuberculosis. J. Immunol. 2007, 178(11):7222-7234.
36. Bhatia S., et al. B7-1 and B7-2: similar costimulatory ligands with different biochemical, oligomeric and signaling properties. Immunol. Lett. 2006, 104(1-2):70-75.
37. Pentcheva-Hoang T., et al. B7-1 and B7-2 selectively recruit CTLA-4 and CD28 to the immunological synapse. Immunity 2004, 21(3):401-413.